Journal

Journal of Nuclear Medicine

0161-5505 · Society of Nuclear Medicine

34 verified public works

Browse all journals →

Evaluation of the In Vivo PET Generator 140 Nd/ 140 Pr Using a HER2-Targeting Agent

2026 · 0 citations

Nectin-4–Targeted PET/CT Before Organ-Sacrificing Surgery for Occult Ureteral Carcinoma

2026 · 0 citations

Fully Automated Segmentation of [ 18 F]FDG and [ 68 Ga]/[ 18 F]PSMA PET/CT Images via Data-Centric Deep Learning

2026 · 0 citations

Head-to-Head Comparison of Neuroblastoma Detection by [ 64 Cu]GD2 PET and [ 123 I]MIBG SPECT

2026 · 0 citations

Clinical Imaging of 225 Ac in a PET Scanner via Time-of-Flight Cascade γ-Ray Imaging

2026 · 0 citations

Radioiodine Spill–Induced Radiation Dermatitis

2026 · 0 citations

A Conversation Between Arturo Chiti and Johannes Czernin

2026 · 0 citations

High Quantitative Accuracy Is Possible with 177 Lu SPECT

2026 · 0 citations

Clinical Trial Protocol for LPS-Boost: Intensified [ 177 Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA–Expressing Disease

2026 · 0 citations

Reply LTE, High Quantitative Accuracy is Possible with 177Lu SPECT…

2026 · 0 citations

Patient Survival and Its Relation to Tumor Absorbed Dose in [ 177 Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors

2026 · 0 citations

Normal Tissue Dosimetry of Intraperitoneal 224 Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal Metastases

2026 · 0 citations

Real-World Outcomes of [ 177 Lu]Lu-PSMA-617 in the French Early-Access Program for Patients with Metastatic Castration-Resistant Prostate Cancer

2026 · 0 citations

Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells

2026 · 0 citations

Medicine Often Mistakes the Present for the Future

2026 · 0 citations

Neuroinflammatory PET in Epilepsy: Prospects for Epileptogenic Zone Localization and Presurgical Planning

2026 · 0 citations

A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [ 177 Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)

2026 · 0 citations

Tumor and Organ Dose Estimates from 177 Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial

2026 · 0 citations

Concerns Regarding Brain [ 18 F]FDG SUV mean as a Prognostic Biomarker in Advanced Non–Small Cell Lung Cancer

2026 · 0 citations

Reply: Concerns Regarding Brain [ 18 F]FDG SUV mean as a Prognostic Biomarker in Advanced Non–Small Cell Lung Cancer

2026 · 0 citations

Evaluation of 9-Minute Dual-Energy Peak Time–Reduced 360° CZT Total-Body [ 177 Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [ 68 Ga]Ga-PSMA PET

2026 · 0 citations

Evaluating Interim Progression: First Posttherapy 177 Lu-PSMA SPECT/CT Relative to Baseline PSMA PET/CT

2026 · 0 citations

Outcome Prediction After [ 177 Lu]Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: External Validation of a [ 68 Ga]Ga-PSMA-11 PET–Based Model with [ 18 F]F-Flotufolastat

2026 · 0 citations

Clinical Impact and Dynamics of Clonal Hematopoiesis with 177 Lu-PSMA-617 Therapy in Advanced Prostate Cancer

2026 · 0 citations

Combining an α v β 6 -Targeted 177 Lu-Based Peptide Receptor Radionuclide Therapy with Olaparib to Boost Therapeutic Efficacy in Pancreatic Cancer

2026 · 0 citations

Update to “Renal and Multiorgan Safety of 177 Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy”

2026 · 0 citations

2025 SNMMI Basic Sciences Summary Session Highlight Lectures: Physics, Instrumentation, and Data Sciences

2026 · 0 citations

Prognostic Value of a Composite Score Incorporating Baseline [ 18 F]FDG PET/CT and [ 68 Ga]Ga-PSMA-11 PET/CT When Screening for [ 177 Lu]Lu-PSMA Treatment Eligibility (PROFILE Study)

2026 · 0 citations

Associations of [ 18 F]PI-2620 Binding with Memory and Phosphorylated Tau 217 in Cognitively Unimpaired Older Adults

2026 · 0 citations

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined 18 F-Flotufolastat PSMA PET and mpMRI

2026 · 0 citations